These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1232331)

  • 61. [Fluoride osteosis of hydro-telluric origin in a female patient with renal insufficiency. Apropos of a case with histomorphometric analysis].
    Hurault de Ligny B; Gilson B; Mariot A; Kessler M; Arlot A; Meunier PJ; Huriet C
    Sem Hop; 1984 Jan; 60(2):119-23. PubMed ID: 6322326
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 63. [Radiological study of the hand of patients undergoing periodic hemodialysis. Possibilities and limitations of the method as an index of the evolution of the uremic disease].
    Fabbri L; Fusaroli M; Losinno F; Pavlica P; Stasi G; Viglietta G
    Radiol Med; 1979; 65(1-2):11-9. PubMed ID: 461842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of chronic uremia in childhood. II. Hemodialysis.
    Potter D; Larsen D; Leumann E; Perin D; Simmons J; Piel CF; Holliday MA
    Pediatrics; 1970 Nov; 46(5):678-89. PubMed ID: 4921218
    [No Abstract]   [Full Text] [Related]  

  • 65. Bone disease in chronic renal failure.
    Malhotra KK; Gadekar NG; Umashankar P; Bhargava S
    Indian J Med Res; 1968 Nov; 56(11):1687-95. PubMed ID: 5715968
    [No Abstract]   [Full Text] [Related]  

  • 66. [Mortality in patients with chronic renal insufficiency undergoing hemodialysis. Hyperlipemia as coadjuvant factor].
    Joven J; Vilella E; Brunzell JD
    Med Clin (Barc); 1991 Jan; 96(3):110-3. PubMed ID: 2033971
    [No Abstract]   [Full Text] [Related]  

  • 67. [Osteopathy in long-term dialysis. Diagnostic parameters and pathogenetic factors].
    Ritz E; Krempien N; Andrassy K
    Verh Dtsch Ges Inn Med; 1972; 78():1456-9. PubMed ID: 4665582
    [No Abstract]   [Full Text] [Related]  

  • 68. Experience with aluminum-associated bone disease in end-stage renal disease patients.
    Joglar FM; Rivera CG; Burgos R; Huffer WE
    Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166
    [No Abstract]   [Full Text] [Related]  

  • 69. [Changes in the gastrointestinal tract in patients with chronic renal insufficiency treated by hemodialysis].
    Ryss ES
    Klin Med (Mosk); 1976 Jun; 54(6):15-7. PubMed ID: 972507
    [No Abstract]   [Full Text] [Related]  

  • 70. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hyrparathyroidism in renal insufficiency treated by hemodialysis and transplantation].
    Zech P; Perinetti M; Moskovtchenko JF; Pozet N; Meunier P; Traeger J
    Rein Foie; 1970; 13():223-50. PubMed ID: 4926838
    [No Abstract]   [Full Text] [Related]  

  • 72. [Therapy of terminal renal insufficiency].
    Hallauer W
    Med Klin; 1974 Apr; 69(14):561-73. PubMed ID: 4600334
    [No Abstract]   [Full Text] [Related]  

  • 73. Maintenance hemodialysis--a clinical review.
    Feng PH; Reisin E; Weinberg U; Jonas P; Iaina A; Iliahou HE
    Singapore Med J; 1971 Jun; 12(3):173-5. PubMed ID: 4328666
    [No Abstract]   [Full Text] [Related]  

  • 74. [X-ray characteristics of the changes in the bones and soft tissues during prolonged hemodialysis].
    Diankov LA; Sarkaniats AM; Frantsov SI; Bynkova MP; Todorov KI
    Vestn Rentgenol Radiol; 1978; (3):45-51. PubMed ID: 685117
    [No Abstract]   [Full Text] [Related]  

  • 75. [Relationship between x-ray bone changes and the levels of alkaline phosphatase and of the calcium-phosphate products in chronic kidney failure during hemodialysis].
    Mocek J; Safrànek I; Sadìlková M; Svacina P
    Vnitr Lek; 1973 May; 19(5):426-32. PubMed ID: 4710487
    [No Abstract]   [Full Text] [Related]  

  • 76. [Hepatic disorders in patients with chronic terminal renal insufficiency in hemodialysis, transplant or peritoneal dialysis].
    Wolpert E; Neri E; Lira MA; Peña JC; Chávez Peón F
    Gac Med Mex; 1987; 123(5-6):113-7. PubMed ID: 3315816
    [No Abstract]   [Full Text] [Related]  

  • 77. Dental management for children with chronic renal failure undergoing hemodialysis therapy.
    Chow MH; Peterson DS
    Oral Surg Oral Med Oral Pathol; 1979 Jul; 48(1):34-8. PubMed ID: 287985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term hemodialysis in the elderly.
    Ghantous WN; Bailey GL; Zschaeck D; Hampers CL; Merrill JP
    Trans Am Soc Artif Intern Organs; 1971; 17():125-8. PubMed ID: 4945708
    [No Abstract]   [Full Text] [Related]  

  • 79. [Complications of percutaneous catheterization of the femoral artery for hemodialysis. Apropos of 3 cases].
    Naranjo Gómez P; Alvarez Otero MJ; García de Lomana T; Coronel Díaz F; Sierra Barcena E; Prats Sánchez D
    Rev Clin Esp; 1980 Mar; 156(5):325-7. PubMed ID: 7384580
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.